WeChat Mini Program
Old Version Features

P60.11 TCR Repertoire Predicts Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy from NADIM Trial

M. Casarrubios,E. Nadal,A. Cruz-Bermudez,A. Insa,R. Laza Briviesca,M. R. Garcia Campelo,B. Sierra-Rodero,J. Casal,M. Domine,B. Massuti,M. Majem Tarruella,D. Rodriguez-Abreu,A. Martinez-Marti,J. De Castro Campeno,M. Cobo Dols,G. Lopez Vivanco,E. Del Barco,R. Bernabe Caro,N. Vinolas,I. Barneto,S. Viteri,M. Jove,F. Franco,M. Provencio

JOURNAL OF THORACIC ONCOLOGY（2021）

Cited 1|Views17
Key words
TCR,NSCLC,neoadjuvant,chemoimmunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined